Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Burdick, Ph.D.

Concepts (352)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Katherine Burdick's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Katherine Burdick has written about over time.
Schizophrenic Psychology, 23 publications between 2005 and 2019, average publication date August 2009. Schizophrenia, 52 publications between 2005 and 2023, average publication date May 2011. Psychotic Disorders, 13 publications between 2005 and 2022, average publication date March 2012. Cognition Disorders, 41 publications between 2001 and 2024, average publication date April 2012. Dopamine Agonists, 4 publications between 2004 and 2021, average publication date October 2012. Endophenotypes, 3 publications between 2012 and 2013, average publication date February 2013. Neuropsychological Tests, 56 publications between 2005 and 2024, average publication date August 2013. Bipolar Disorder, 87 publications between 2001 and 2024, average publication date February 2016. Cognition, 57 publications between 2005 and 2024, average publication date June 2016. Nootropic Agents, 5 publications between 2007 and 2021, average publication date September 2016. Social Behavior, 4 publications between 2015 and 2019, average publication date May 2017. Depressive Disorder, Major, 8 publications between 2004 and 2024, average publication date January 2018. Lithium, 3 publications between 2020 and 2023, average publication date May 2022.

To see the data from this visualization as text, click here.
Burdick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (352)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.